blems with initiatives that include:
Training 250 new racially and ethnically diverse clinical investigators over a five-year span to help enroll underserved patients to clinical trials.
Accelerating efforts to reach at-risk patients with more education programs and information about programs for people who can’t afford medication.
Spending $1 billion globally by 2025 with suppliers owned by people of color.
Maurice Williams
Comments